Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
6.18
-0.22 (-3.44%)
Feb 12, 2026, 9:54 AM EST - Market open
Solid Biosciences Market Cap
Solid Biosciences has a market cap or net worth of $481.49 million as of February 12, 2026. Its market cap has increased by 283.65% in one year.
Market Cap
481.49M
Enterprise Value
284.42M
1-Year Change
283.65%
Ranking
Category
Stock Price
$6.18
Market Cap Chart
Since January 26, 2018, Solid Biosciences's market cap has decreased from $754.10M to $481.49M, a decrease of -36.15%. That is a compound annual growth rate of -5.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 539.90M | 22.87% |
| Dec 31, 2025 | 439.40M | 174.97% |
| Dec 31, 2024 | 159.80M | 28.97% |
| Dec 29, 2023 | 123.90M | 205.93% |
| Dec 30, 2022 | 40.50M | -79.02% |
| Dec 31, 2021 | 193.00M | -57.88% |
| Dec 31, 2020 | 458.20M | 123.95% |
| Dec 31, 2019 | 204.60M | -78.45% |
| Dec 31, 2018 | 949.60M | 25.92% |
| Jan 26, 2018 | 754.10M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vor Biopharma | 543.49M |
| Gossamer Bio | 542.76M |
| Evommune | 539.03M |
| Keros Therapeutics | 534.98M |
| REGENXBIO | 534.07M |
| Forte Biosciences | 522.46M |
| Lexeo Therapeutics | 520.40M |
| Tenax Therapeutics | 516.46M |